| Financial Year |
March 31 2023 |
| Monetary Funds |
110,567,441.35 |
| Held-for-trading Financial Assets |
109,494.77 |
| Notes Receivable |
12,818,307.71 |
| Accounts Receivable |
674,358,669.32 |
| Advances to Suppliers |
83,173,931.21 |
| Other Receivables |
59,104,934.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
279,854,402.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,140,000.00 |
| Other Current Assets |
13,513,308.61 |
| Total Current Assets |
1,247,106,640.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,140,000.00 |
| Long-term Equity Investment |
126,992,360.56 |
| Investment Properties |
99,866,659.20 |
| Fixed Assetes |
323,579,798.18 |
| Under-construction Projects |
153,714,730.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
141,500,523.04 |
| R&D expenses |
-- |
| Goodwill |
4,111,401.55 |
| Long-Term Deferred and Prepaid Expenses |
261,437.38 |
| Deferred Income Tax Assets |
59,970,939.11 |
| Other Non-Current Assets |
3,560,392.58 |
| Sub-Total of Non-Current Assets |
920,698,242.51 |
| Total Assets |
2,167,804,882.94 |
| Short-Term Loans |
60,031,013.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
509,836,135.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
180,594.93 |
| Taxes Payable |
6,303,497.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,192,230.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,004,526.42 |
| Other Current Liabilities |
22,121,349.35 |
| Sub-Total of Current Liabilities |
716,050,040.77 |
| Long-term Loans |
63,750,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
452,370.40 |
| Deferred Income Tax Liabilities |
2,057,833.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
67,380,442.40 |
| Total Liabilities |
783,430,483.17 |
| Paid-In Capital(Or Share Stock) |
1,040,921,518.00 |
| Capital Surplus |
94,411,346.51 |
| Surplus Reserve |
38,220,667.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
194,613,288.82 |
| Minority Stockholder's Interest |
4,083,921.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,380,290,478.28 |
| Owner's Equity（Stockholder's Equity） |
1,384,374,399.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,167,804,882.94 |
